Terms: = Kidney tumors AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
26 results:
1. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
2. Expression Pattern of Sonic Hedgehog, Patched and smoothened in Clear Cell Renal Carcinoma.
Dunatov Huljev A; Kelam N; Benzon B; Šoljić V; Filipović N; Pešutić Pisac V; Glavina Durdov M; Vukojević K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240278
[TBL] [Abstract] [Full Text] [Related]
3. ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression.
Tang C; Li L; Xu Q; Xu S; Lin C; Cao B
Mol Carcinog; 2023 Jun; 62(6):882-893. PubMed ID: 36988340
[TBL] [Abstract] [Full Text] [Related]
4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
5. Inhibitory Effect of Ursolic Acid on Proliferation and Migration of Renal Carcinoma Cells and Its Mechanism.
Lyu X; Zhang X; Sun L; Wang J; Wang D
Comput Intell Neurosci; 2022; 2022():1529132. PubMed ID: 35571705
[TBL] [Abstract] [Full Text] [Related]
6. Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma.
Kotulak-Chrzaszcz A; Rybarczyk A; Klacz J; Matuszewski M; Kmiec Z; Wierzbicki PM
Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35266008
[TBL] [Abstract] [Full Text] [Related]
7. New predictive factors for prolonged operation time of laparoscopic posterior retroperitoneal adrenalectomy; retrospective cohort study.
Rah CS; Kim WW; Lee YM; Chung KW; Koh JM; Lee SH; Hong SJ; Sung TY
Int J Surg; 2021 Oct; 94():106113. PubMed ID: 34534705
[TBL] [Abstract] [Full Text] [Related]
8. Sonic Hedgehog signaling pathway in gynecological and genitourinary cancer (Review).
Kotulak-Chrząszcz A; Kmieć Z; Wierzbicki PM
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907821
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
Basili T; Dopeso H; Kim SH; Ferrando L; Pareja F; Da Cruz Paula A; da Silva EM; Stylianou A; Maroldi A; Marchiò C; Rubin BP; Papotti M; Weigelt B; Moreira Ferreira CG; Lapa E Silva JR; Reis-Filho JS
Int J Cancer; 2020 Oct; 147(8):2253-2264. PubMed ID: 32383186
[TBL] [Abstract] [Full Text] [Related]
10. A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.
Park I; Lee HJ; Bae WK; Yoon S; Lee JL
Invest New Drugs; 2019 Dec; 37(6):1239-1246. PubMed ID: 31231787
[TBL] [Abstract] [Full Text] [Related]
11. Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.
Chen X; Zhou Z; Hannan R; Thomas K; Pedrosa I; Kapur P; Brugarolas J; Mou X; Wang J
Phys Med Biol; 2018 Oct; 63(21):215008. PubMed ID: 30277889
[TBL] [Abstract] [Full Text] [Related]
12. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract] [Full Text] [Related]
13. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract] [Full Text] [Related]
14. Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target.
Zhou J; Zhu G; Huang J; Li L; Du Y; Gao Y; Wu D; Wang X; Hsieh JT; He D; Wu K
Cancer Lett; 2016 Jan; 370(2):313-23. PubMed ID: 26577809
[TBL] [Abstract] [Full Text] [Related]
15. Reciprocal regulation of hypoxia-inducible factor 2α and GLI1 expression associated with the radioresistance of renal cell carcinoma.
Zhou J; Wu K; Gao D; Zhu G; Wu D; Wang X; Chen Y; Du Y; Song W; Ma Z; Authement C; Saha D; Hsieh JT; He D
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):942-51. PubMed ID: 25585786
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.
D'Amato C; Rosa R; Marciano R; D'Amato V; Formisano L; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fulciniti F; Cipolletta A; Bianco C; Ciardiello F; Veneziani BM; De Placido S; Bianco R
Br J Cancer; 2014 Sep; 111(6):1168-79. PubMed ID: 25093491
[TBL] [Abstract] [Full Text] [Related]
17. DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma.
Jäger W; Thomas C; Fazli L; Hurtado-Coll A; Li E; Janssen C; Gust KM; So AI; Hainz M; Schmidtmann I; Roos FC; Thüroff JW; Brenner W; Black PC
J Urol; 2014 Dec; 192(6):1842-8. PubMed ID: 25046620
[TBL] [Abstract] [Full Text] [Related]
18. miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened.
Sun K; Deng HJ; Lei ST; Dong JQ; Li GX
World J Gastroenterol; 2013; 19(14):2197-207. PubMed ID: 23599646
[TBL] [Abstract] [Full Text] [Related]
19. Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.
Jonasch E; Lal LS; Atkinson BJ; Byfield SD; Miller LA; Pagliaro LC; Feng C; Tannir NM
BJU Int; 2011 Mar; 107(5):741-747. PubMed ID: 21355978
[TBL] [Abstract] [Full Text] [Related]
20. Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
Karakiewicz PI; Trinh QD; Rioux-Leclercq N; de la Taille A; Novara G; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Lechevallier E; Coulange C; Valeri A; Descotes JL; Rambeaud JJ; Abbou CC; Lang H; Jacqmin D; Mejean A; Patard JJ
Eur Urol; 2007 Oct; 52(4):1140-5. PubMed ID: 17336449
[TBL] [Abstract] [Full Text] [Related]
[Next]
